Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.

In what many see as a delay in USPTO response? In view of their financial situation....could it benefit them, in any way, having this action delayed? I might only suggest that a strong NIRC response would put great pressure on them to deliver and until they resolve their problems.....this ain't happening. One has to figure, this situation would also limit share price appreciation. This would hurt us, PTSC and Tpl, if in fact Leckrones own as much stock as they have boasted about. This leads me to my main thought. Depending on their holdings of PTSC....they could finance their efforts by sale pf stock in PTSC if it were to appreciate significantly.

Please login to post a reply
beantown
City
Rank
Treasurer
Activity Points
4116
Rating
Your Rating
Date Joined
12/14/2004
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post